Anemia, hematinic deficiencies, hyperhomocysteinemia, and gastric parietal cell antibody positivity in burning mouth syndrome patients with normocytosis.

Anemia Burning mouth syndrome Hyperhomocysteinemia Normocytosis Vitamin B12 deficiency

Journal

Journal of dental sciences
ISSN: 2213-8862
Titre abrégé: J Dent Sci
Pays: Netherlands
ID NLM: 101293181

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 09 09 2021
entrez: 14 1 2022
pubmed: 15 1 2022
medline: 15 1 2022
Statut: ppublish

Résumé

Normocytosis is defined as having the mean corpuscular volume (MCV) between 80 fL and 99.9 fL. This study evaluated whether 770 burning mouth syndrome (BMS) patients with normocytosis (so-called normocytosis/BMS patients) had significantly higher frequencies of anemia, hematinic deficiencies, hyperhomocysteinemia, and serum gastric parietal cell antibody (GPCA) positivity than 442 healthy control subjects or 884 BMS patients. Complete blood count, serum iron, vitamin B12, folic acid, homocysteine, and GPCA levels in 884 BMS patients (including 770 normocytosis/BMS patients) and 442 healthy control subjects were measured and compared. We found that 12.3%, 13.2%, 2.2%, 2.3%, 17.3%, and 10.5% of 770 normocytosis/BMS patients had blood hemoglobin (Hb), iron, vitamin B12, and folic acid deficiencies, hyperhomocysteinemia, and serum GPCA positivity, respectively. Furthermore, 770 normocytosis/BMS patients had significantly higher frequencies of blood Hb, iron, vitamin B12, and folic acid deficiencies, hyperhomocysteinemia, and serum GPCA positivity than 442 healthy control subjects (all We conclude that there are significantly higher frequencies of anemia, serum iron, vitamin B12, and folic acid deficiencies, hyperhomocysteinemia, and serum GPCA positivity in normocytosis/BMS patients than in healthy control subjects. On the contrary, normocytosis/BMS patients do have significantly lower frequencies of blood Hb and vitamin B12 deficiencies than overall BMS patients.

Sections du résumé

BACKGROUND/PURPOSE OBJECTIVE
Normocytosis is defined as having the mean corpuscular volume (MCV) between 80 fL and 99.9 fL. This study evaluated whether 770 burning mouth syndrome (BMS) patients with normocytosis (so-called normocytosis/BMS patients) had significantly higher frequencies of anemia, hematinic deficiencies, hyperhomocysteinemia, and serum gastric parietal cell antibody (GPCA) positivity than 442 healthy control subjects or 884 BMS patients.
MATERIALS AND METHODS METHODS
Complete blood count, serum iron, vitamin B12, folic acid, homocysteine, and GPCA levels in 884 BMS patients (including 770 normocytosis/BMS patients) and 442 healthy control subjects were measured and compared.
RESULTS RESULTS
We found that 12.3%, 13.2%, 2.2%, 2.3%, 17.3%, and 10.5% of 770 normocytosis/BMS patients had blood hemoglobin (Hb), iron, vitamin B12, and folic acid deficiencies, hyperhomocysteinemia, and serum GPCA positivity, respectively. Furthermore, 770 normocytosis/BMS patients had significantly higher frequencies of blood Hb, iron, vitamin B12, and folic acid deficiencies, hyperhomocysteinemia, and serum GPCA positivity than 442 healthy control subjects (all
CONCLUSION CONCLUSIONS
We conclude that there are significantly higher frequencies of anemia, serum iron, vitamin B12, and folic acid deficiencies, hyperhomocysteinemia, and serum GPCA positivity in normocytosis/BMS patients than in healthy control subjects. On the contrary, normocytosis/BMS patients do have significantly lower frequencies of blood Hb and vitamin B12 deficiencies than overall BMS patients.

Identifiants

pubmed: 35028018
doi: 10.1016/j.jds.2021.09.025
pii: S1991-7902(21)00235-X
pmc: PMC8740384
doi:

Types de publication

Journal Article

Langues

eng

Pagination

35-41

Informations de copyright

© 2021 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier B.V.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest relevant to this article.

Références

Hematology Am Soc Hematol Educ Program. 2012;2012:183-90
pubmed: 23233579
Am Fam Physician. 2000 Nov 15;62(10):2255-64
pubmed: 11126852
J Formos Med Assoc. 2014 Feb;113(2):83-7
pubmed: 24388269
J Formos Med Assoc. 2017 Aug;116(8):613-619
pubmed: 28314600
J Formos Med Assoc. 2019 Sep;118(9):1299-1307
pubmed: 31202497
Am J Clin Nutr. 2007 Jan;85(1):193-200
pubmed: 17209196
J Dent Sci. 2020 Mar;15(1):42-49
pubmed: 32256999
J Dent Sci. 2021 Mar;16(2):608-613
pubmed: 33854709
J Formos Med Assoc. 2021 Feb;120(2):819-826
pubmed: 32888843
J Dent Sci. 2020 Mar;15(1):34-41
pubmed: 32256998
Blood Rev. 2014 Mar;28(2):49-66
pubmed: 24560123
J Formos Med Assoc. 2015 Sep;114(9):806-12
pubmed: 26187724
Am Fam Physician. 1997 May 15;55(7):2455-62
pubmed: 9166144
J Dent Sci. 2021 Oct;16(4):1133-1139
pubmed: 34484580
Br Med J. 1962 Nov 24;2(5316):1347-52
pubmed: 13993616
Arch Pharm Res. 2018 Apr;41(4):372-383
pubmed: 29552692
J Formos Med Assoc. 2020 Apr;119(4):813-820
pubmed: 31679908
J Formos Med Assoc. 2020 Dec;119(12):1758-1763
pubmed: 32883568
J Dent Sci. 2021 Oct;16(4):1110-1116
pubmed: 34484577
Oral Dis. 2013 May;19(4):381-6
pubmed: 22957902
J Dent Sci. 2021 Jul;16(3):846-853
pubmed: 34141098
J Formos Med Assoc. 2016 Dec;115(12):1061-1068
pubmed: 27839675
Food Nutr Bull. 2008 Jun;29(2 Suppl):S238-44
pubmed: 18709899
N Engl J Med. 2006 Apr 13;354(15):1567-77
pubmed: 16531613
Alcohol Clin Exp Res. 2005 Mar;29(3):334-6
pubmed: 15770107
J Formos Med Assoc. 2015 Jun;114(6):532-8
pubmed: 25886860
J Dent Sci. 2020 Jun;15(2):214-221
pubmed: 32595904
J Environ Pathol Toxicol Oncol. 2018;37(3):241-259
pubmed: 30317974
J Formos Med Assoc. 2018 Dec;117(12):1065-1071
pubmed: 30087017
J Formos Med Assoc. 2018 Mar;117(3):227-234
pubmed: 29292055
Lancet. 1959 Aug 15;2(7094):106-8
pubmed: 13837172
Alcohol Alcohol. 2001 May-Jun;36(3):189-92
pubmed: 11373253
J Oral Pathol Med. 2016 Jan;45(1):23-7
pubmed: 25990467
Am Fam Physician. 2003 Mar 1;67(5):979-86
pubmed: 12643357
World J Gastroenterol. 2009 Nov 7;15(41):5121-8
pubmed: 19891010
J Formos Med Assoc. 2015 Aug;114(8):736-41
pubmed: 25935499
Arch Intern Med. 1999 Jun 28;159(12):1289-98
pubmed: 10386505

Auteurs

Yu-Hsueh Wu (YH)

Department of Stomatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Institute of Oral Medicine, School of Dentistry, National Cheng Kung University, Tainan, Taiwan.

Ying-Tai Jin (YT)

Department of Pathology, Taiwan Adventist Hospital, Taipei, Taiwan.
Department of Pathology, National Cheng Kung University Hospital, Tainan, Taiwan.

Yang-Che Wu (YC)

School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
Department of Dentistry, Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City, Taiwan.

Julia Yu-Fong Chang (JY)

Department of Dentistry, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University, Taipei, Taiwan.
Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan.

Chun-Pin Chiang (CP)

Department of Dentistry, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University, Taipei, Taiwan.
Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan.
Department of Dentistry, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

Andy Sun (A)

Department of Dentistry, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University, Taipei, Taiwan.
Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan.

Classifications MeSH